← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2014-10-31

Drug application

FDA Application #

ANDA203564

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

LAMIVUDINE ORAL

Active ingredients

LAMIVUDINE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2014-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown